Skip to main content
Clinical Trials/ACTRN12611001286932
ACTRN12611001286932
Completed
未知

In patients with idiopathic interstitial pneumonia, nocturnal supplemental oxygen compared with placebo, improves sleep and quality of life

Royal Prince Alfred Hospital0 sites30 target enrollmentDecember 15, 2011

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Royal Prince Alfred Hospital
Enrollment
30
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 15, 2011
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients 18 \- 80 yrs.
  • Patients able to perform a polysomnogram (sleep study), as determined following clinical assessment.
  • Patients with nocturnal hypoxaemia, defined as \>10% of the night with SpO2 \<90% on overnight oximetry or PSG
  • Patients able to give informed consent.
  • Patients with idiopathic interstitial pneumonia (IIP), according to American Thoracic Society /European Respiratory Society criteria.
  • Absence of daytime resting hypoxaemia (ie with PaO2 \> 55mmHg).

Exclusion Criteria

  • Patients \<18yrs or \>80yrs.
  • Patients not able to give informed consent.
  • Patients considered unable to complete a PSG by their physician.
  • Presence of daytime resting hypoxaemia (PaO2 less than or equal to 55mmHg).
  • Presence of hypercapnia (PaCO2 \> 45mmHg) at baseline
  • Patients who do not meet oxygen saturation criteria for nocturnal hypoxaemia
  • Patients with co\-existent obstructive sleep apnoea with apnoea hypopnoea index greater than or equal to 15 with clinical symptoms, or apnoea hypopnoea index greater than or equal to 30 (without symptoms)
  • Patients who are current smokers

Outcomes

Primary Outcomes

Not specified

Similar Trials